GWPH - GW Pharma updates plan to commercialize nabiximols in U.S. June, 30 2020 07:31 AM GW Pharmaceuticals Plc GW Pharmaceuticals (NASDAQ:GWPH) announces strategy for bringing its pipeline product nabiximols to the U.S. market.More news on: GW Pharmaceuticals plc, Healthcare stocks news, Read more ...